B. C. Millar

772 total citations
34 papers, 610 citations indexed

About

B. C. Millar is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, B. C. Millar has authored 34 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hematology, 12 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in B. C. Millar's work include Multiple Myeloma Research and Treatments (21 papers), Hematopoietic Stem Cell Transplantation (10 papers) and Cancer Treatment and Pharmacology (6 papers). B. C. Millar is often cited by papers focused on Multiple Myeloma Research and Treatments (21 papers), Hematopoietic Stem Cell Transplantation (10 papers) and Cancer Treatment and Pharmacology (6 papers). B. C. Millar collaborates with scholars based in United Kingdom, Canada and New Zealand. B. C. Millar's co-authors include V Shepherd, T J McElwain, C. Viner, Seema Singhal, S Kulkarni, Martin Gore, J Treleaven, R Powles, S Milan and M Meldrum and has published in prestigious journals such as The Lancet, British Journal of Cancer and Carcinogenesis.

In The Last Decade

B. C. Millar

34 papers receiving 592 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. C. Millar United Kingdom 13 498 228 224 110 65 34 610
Kathleen Dugan United States 9 313 0.6× 356 1.6× 253 1.1× 50 0.5× 115 1.8× 11 660
R Bailey-Wood United Kingdom 13 272 0.5× 131 0.6× 318 1.4× 342 3.1× 70 1.1× 23 682
Jeana Cromer United States 6 802 1.6× 413 1.8× 557 2.5× 63 0.6× 64 1.0× 6 870
Catherine Godon France 11 307 0.6× 192 0.8× 348 1.6× 40 0.4× 105 1.6× 24 556
PJ Burke United States 15 376 0.8× 362 1.6× 410 1.8× 49 0.4× 88 1.4× 26 803
G.J. Schuurhuis Netherlands 11 146 0.3× 289 1.3× 230 1.0× 86 0.8× 39 0.6× 18 489
Harald Biersack Germany 13 196 0.4× 242 1.1× 219 1.0× 71 0.6× 72 1.1× 33 560
Masanori Umeda Japan 15 113 0.2× 145 0.6× 275 1.2× 53 0.5× 68 1.0× 59 533
Toshiya Yokozawa Japan 8 222 0.4× 100 0.4× 281 1.3× 63 0.6× 107 1.6× 17 528
Anna Grazia Recchia Italy 16 302 0.6× 166 0.7× 265 1.2× 79 0.7× 151 2.3× 38 653

Countries citing papers authored by B. C. Millar

Since Specialization
Citations

This map shows the geographic impact of B. C. Millar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. C. Millar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. C. Millar more than expected).

Fields of papers citing papers by B. C. Millar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. C. Millar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. C. Millar. The network helps show where B. C. Millar may publish in the future.

Co-authorship network of co-authors of B. C. Millar

This figure shows the co-authorship network connecting the top 25 collaborators of B. C. Millar. A scholar is included among the top collaborators of B. C. Millar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. C. Millar. B. C. Millar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Martin, Francis L., K J Cole, David Harvey, et al.. (2000). DNA damage in human breast milk cells and its induction by  early  and  late  milk extracts. Carcinogenesis. 21(4). 799–804. 17 indexed citations
2.
3.
Singhal, Seema, R Powles, S Kulkarni, et al.. (2000). Comparison of marrow and blood cell yields from the same donors in a double-blind, randomized study of allogeneic marrow vs blood stem cell transplantation. Bone Marrow Transplantation. 25(5). 501–505. 36 indexed citations
4.
Millar, B. C., Jeremy Millar, V Shepherd, et al.. (1998). The importance of CD34+/CD33− cells in platelet engraftment after intensive therapy for cancer patients given peripheral blood stem cell rescue. Bone Marrow Transplantation. 22(5). 469–475. 27 indexed citations
5.
Powles, R, Noopur Raje, S Milan, et al.. (1997). Outcome assessment of a population-based group of 195 unselected myeloma patients under 70 years of age offered intensive treatment. Bone Marrow Transplantation. 20(6). 435–443. 55 indexed citations
6.
Raje, Noopur, R Powles, C Horton, et al.. (1997). Comparison of marrow vs blood-derived stem cells for autografting in previously untreated multiple myeloma. British Journal of Cancer. 75(11). 1684–1689. 18 indexed citations
7.
Millar, B. C., et al.. (1996). Lymphocyte recovery and clinical response in multiple myeloma patients receiving interferon alpha 2 beta after intensive therapy. British Journal of Cancer. 73(2). 236–240. 2 indexed citations
8.
Mehta, Jayesh, R Powles, Seema Singhal, et al.. (1996). High-dose Hydroxyurea and G-CSF to Collect Philadelphia-Negative Cells in Chronic Myeloid Leukemia: Preliminary Results. Leukemia & lymphoma. 23(1-2). 107–111. 3 indexed citations
9.
10.
11.
Mahendra, Premini, Rita Barfoot, J. B. G. Bell, et al.. (1994). TGFβ1and IL-4 Have Opposing Effects on the Proliferation of Chronic Phase Chronic Myeloid Leukaemic Cells Stimulated by G-CSF In Vitro. Leukemia & lymphoma. 12(5-6). 449–455. 2 indexed citations
12.
Barfoot, Rita, et al.. (1994). Neutralising antibodies in patients with multiple myeloma receiving maintenance therapy with interferon α2b. British Journal of Cancer. 70(4). 646–651. 8 indexed citations
13.
14.
Millar, B. C., J. B. G. Bell, Jeremy Millar, et al.. (1990). Interleukin‐6 is a cofactor for the growth of myeloid cells from human bone marrow aspirates but does not affect the clonogenicity of myeloma cells in vitro. British Journal of Haematology. 76(4). 476–483. 20 indexed citations
15.
16.
Millar, B. C., et al.. (1989). Melphalan transport into human malignant lymphoid cells differs from the murine equivalent in vitro. British Journal of Cancer. 59(5). 710–713. 4 indexed citations
17.
Millar, B. C., J. B. G. Bell, A. Zuiable, et al.. (1989). In vitro studies of ways to overcome resistance to VAMP‐high dose melphalan in the treatment of multiple myeloma. British Journal of Haematology. 71(2). 213–222. 14 indexed citations
18.
Gore, Martin, C. Viner, M Meldrum, et al.. (1989). INTENSIVE TREATMENT OF MULTIPLE MYELOMA AND CRITERIA FOR COMPLETE REMISSION. The Lancet. 334(8668). 879–882. 157 indexed citations
19.
20.
Millar, B. C., et al.. (1988). A simple method for culturing myeloma cells from human bone marrow aspirates and peripheral blood in vitro. British Journal of Haematology. 69(2). 197–203. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kathleen Dugan Breakdown of academic impact, for papers by R Bailey-Wood Breakdown of academic impact, for papers by Jeana Cromer Breakdown of academic impact, for papers by Catherine Godon Breakdown of academic impact, for papers by PJ Burke Breakdown of academic impact, for papers by G.J. Schuurhuis Breakdown of academic impact, for papers by Harald Biersack Breakdown of academic impact, for papers by Masanori Umeda Breakdown of academic impact, for papers by Toshiya Yokozawa Breakdown of academic impact, for papers by Anna Grazia Recchia
Rankless by CCL
2026